Getting Under the Skin at May 11 Symposium on Melanoma
The Angeles Clinic and Research Institute, an affiliate of Cedars-Sinai Cancer, is teaming up with the AIM at Melanoma Foundation for the 14th year to host a fr
Stay updated with breaking news from Omid Hamid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Angeles Clinic and Research Institute, an affiliate of Cedars-Sinai Cancer, is teaming up with the AIM at Melanoma Foundation for the 14th year to host a fr
Immunocore announces upcoming presentation and posters at ASCO 2024 Phase 1 expansion data in immune checkpoints pre-treated cutaneous melanoma for brenetafusp to be presented during oral abstract...
Omid Hamid, MD, discusses how lifileucel may address historical unmet needs in relapsed melanoma.
The Food and Drug Administration approve Amtagvi, a TIL therapy, for patients with advanced melanoma who had disease progression on or after a checkpoint inhibitor and targeted therapy.
The panel provides closing thoughts on the future of the CSCC and BCC treatment landscape.